Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

cells

cells is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 313
News articles 0
Drug details — cells
Class
—
Route
—
Patents
20
Programs
313
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

cells is an FDA-listed pharmaceutical active ingredient.

Key facts

INN cells

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 68284528MMY3002 Phase 3 · Janssen-Cilag International N.V · Relapsed and Lenalidomide-Refractory Multiple Myeloma
  2. 68284528MMY3004 Phase 3 · Janssen-Cilag International N.V · Multiple Myeloma
  3. Auto-CD34+ cells Phase 3 · Lisata Therapeutics · Chronic Myocardial Ischemia
  4. CTX001-111 Phase 3 · Vertex Pharmaceuticals (Australia) · Transfusion-dependent β-thalassemia (TDT)
  5. Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion Phase 3 · Vertex Pharmaceuticals (Australia) · Sickle Cell Disease, Transfusion dependent thalassemia
  6. Cytokine-Induced Killer Cells Phase 3 · Sun Yat-sen University · Carcinoma, Hepatocellular
  7. Expanded autologous adipose-derived adult stem cells (eASCs) Phase 3 · Takeda · Complex Perianal Fistula
  8. KT-US-473-0133 Phase 3 · Anaxis Pharma · Relapsed/Refractory Follicular Lymphoma

Related patents

Browse patents

  1. US 12428455

    Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12427170

    Universal donor cells

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12421316

    Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12421302

    CAR-t cells and autoimmune diseases

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12419955

    Method for efficiently infecting human natural killer cells and other immune cells with pseudovirus

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12421517

    Genetic modification of mammalian cells to confer resistance to CSF1R antagonists

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12414968

    Compositions comprising bacterially derived minicells and methods of using the same

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12398373

    Enhanced immune effector cells and use thereof

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12391923

    SIRPα-silenced natural killer (NK) cells

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12391739

    Method for producing gamma delta T cells

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12383629

    DNA-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells overexpressing HER2

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12385013

    Differentiation of pancreatic endocrine cells

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12371665

    Differentiation of pancreatic endocrine cells

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12370256

    Activation of resident memory T cells for the treatment of cancer

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12365873

    Methods for transducing immune cells

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12358968

    Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12351824

    Method for producing natural killer cells from pluripotent stem cells

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12344656

    Genetically engineered T cells having improved persistence in culture

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12343397

    Drug-resistant immune cells and methods of use thereof

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12343448

    Use of stem cells produced by stem cell generator in treatment of hematopoietic damage

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cells?

cells is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.